Anxiety Disorders and Depression Treatment Market will drastically increase

Brandessence Market Research is working on a new report title “Anxiety Disorders and Depression Treatment Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025. Rising mental health issuessuch as depression, anxiety disorders, schizophrenia and growing geriatric population are boosting the global market for anxiety disorders and depression treatment.

Anxiety Disorders and Depression Treatment Market is valued at USD 16.83 Billion in 2018 and expected to reach USD 20.97 Billion by 2025 with the CAGR of 3.19% over the forecast period.

Conditions of depression and anxiety are the most prevalent psychological conditions affecting a large population across the globe. Depression is linked to an emotional state which further affects the individual concerned actions, thoughts and sometimes sleeping patterns. Depression is a brain related psychiatric condition which includes feeling depressed and exhausted, losing motivation and having trouble enjoying every day routine activities.Depression exists mainly because of causes like social isolation and stressful work climate.While anxiety is a natural response to stress that can be helpful in certain cases. Anxiety disorders and depression are distinct, but depressed people frequently experience anxiety disorder like symptoms such as nervousness, irritability, sleeping and concentration issues. Persons with anxiety feeling may interfere with everyday tasks such as job performance, school work and relationships. Anxiety disorders vary from natural feelings of nervousness or anxiety, which include extreme fear or anxiety. High anxiety rates contribute to anxiety disorders that include phobias, obsessive-compulsive disorder, panic disorder, post-traumatic stress-based disorder. There are various effective treatments are available for moderate and severe depression and anxiety. Psychological treatments may be provided by health care providers such as behavioral activation, cognitive behavioral therapy (CBT) and interpersonal psychotherapy (IPT) or antidepressant drugs such as selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs). Specific psychological treatment methods like face-to-face psychological therapies are also provided.

The global anxiety disorders and depression treatment market is segmented on the basis of product, indication and region and country level. On the basis of product, the global anxiety disorders and depression treatment market are classified into drugs, therapy and devices. Based on indication, the anxiety disorders and depression treatment market is classified into major depressive disorder, obsessive- compulsive disorder, phobias and traumatic stress disease.

The regions covered in global anxiety disorders and depression treatment market reports are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, global market is sub divided in U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Get Sample Report: @ https://brandessenceresearch.com/requestSample/PostId/1241

Key Players for Global Anxiety Disorders and Depression Treatment MarketReports –

Global anxiety disorders and depression treatment market reports cover prominent playersEli Lilly and Company, Forest Laboratories, Inc., VistaGen Therapeutics, AstraZeneca PLC, H. Lundbeck A/S, Sanofi-Aventis, Merck & Co., Inc., EverInsight Therapeutics Inc., Pfizer, Inc., GlaxoSmithKline plc, Johnson & Johnson and Others.

Recent News -

VistaGen and EverInsight Enter Strategic Collaboration to Develop and Commercialize PH94B

News: On 22May2018,VistaGen Therapeutics and EverInsight Therapeutics Join strategic partnership to create and market PH94B for anxiety disorders in greater China, South Korea and Southeast Asia. VistaGen Therapeutics is a clinical-stage biopharmaceutical company that develops new generation medicines for central nervous system (CNS) anxiety, depression and other diseases and EverInsight Therapeutics Inc., a biopharmaceutical company dedicated to the development and marketing of transformative pharmaceutical products for patients in Greater China and other parts of Asia. The collaboration between these companies intended to support Phase 3 development and marketing of PH94B in key markets in Asia. The deal involves up to $ 5 million in advance payments and production and trade targets of up to $172 million. Under the terms of the agreement, EverInsight will be responsible for the clinical development, regulatory application, and marketing of PH94B neuroactive nasal spray for acute SAD treatment and possibly other anxiety-related indications on the Greater China (Mainland China, Hong Kong, Macau, and Taiwan), South Korea, and Southeast Asia markets.

Anxiety Disorders and Depression Treatment Market Regional Analysis –

In North America, the global anxiety disorders and depression treatment market is highly attractive due rise in anxiety disorder incidence rate, sedentary lifestyle and stressful work environments are the main factors responsible for rising cases of anxiety disorders. Depression affects around 1 in every 5 individuals in the US, according to CDC. It is estimated that in the United States around 16.2 million adults who accounts approximately 6.7 % of American adults, have experienced at least one major depressive disorder. Anxiety disorders are the most prevalent mental condition in the United States; people with age 18 and older in the United States affected by anxiety around 40 million which account 18.1 % of the population per year.

Europe is considered to be the second largest growing regional anxiety disorders and depression treatment market due to an increasing awareness of anxiety disorders among the public. According to a health News, in Europe with almost 165 million people which accounts nearly 38 % people are afflicted by psychiatric and neurological disorders like depression, anxiety, insomnia or dementia. While in 2017, 1 in every 4 people in the U.K. affected by depression, according to Office for National Statistics.

Asia-Pacific is the fastest growing regional anxiety disorders and depression treatment market, is witnessing an increase in the number of anxiety disorders like generalized anxiety disorder. This growing psychological illness incidence is increasing the need for successful therapy to treat anxiety disorders. These causes will improve care for anxiety disorder.

Key Benefits forAnxiety Disorders and Depression Treatment MarketReports –

· Global anxiety disorders and depression treatment market report covers in depth historical and forecast analysis.

· Global anxiety disorders and depression treatment market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.

· Global anxiety disorders and depression treatment market report helps to identify opportunities in market place.

· Global anxiety disorders and depression treatment market report covers extensive analysis of emerging trends and competitive landscape.

Anxiety Disorders and Depression Treatment MarketSegmentation-

Anxiety Disorders and Depression Treatment Market:By Product

· Drugs

· Therapy

· Devices

Anxiety Disorders and Depression Treatment Market:By Indication

· Major Depressive Disorder

· Obsessive- Compulsive Disorder

· Phobias And Traumatic Stress Disease

Anxiety Disorders and Depression Treatment Market:By Regional &Country Analysis

· North America

o U.S.

o Mexico

o Canada

· Europe

o UK

o France

o Germany

o Italy

· Asia Pacific

o China

o Japan

o India

o Southeast Asia

· South America

o Brazil,

o Argentina

o Columbia

· The Middle East and Africa

o GCC

o Africa

o Rest of Middle East and Africa

Get Full Report: @ https://brandessenceresearch.com/healthcare/anxiety-disorders-and-depression-treatment-market-size

About Us: Brandessence Market Research and Consulting Pvt. ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.